Status: current, Defined. Date: 31-Mar 2022. Module: Australian Medicines Terminology module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 4678201000168110 | sacituzumab govitecan 180 mg injection, 180 mg vial (medicinal product unit of use) | en | Fully specified name | Active | Case sensitive | Australian Medicines Terminology module |
| 4678211000168113 | sacituzumab govitecan 180 mg injection, vial | en | Synonym | Active | Case sensitive | Australian Medicines Terminology module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| sacituzumab govitecan 180 mg injection, vial | Is a | sacituzumab govitecan | true | Inferred relationship | Some | ||
| sacituzumab govitecan 180 mg injection, vial | Is a | medicinal product unit of use | true | Inferred relationship | Some | ||
| sacituzumab govitecan 180 mg injection, vial | has manufactured dose form | injection | true | Inferred relationship | Some | ||
| sacituzumab govitecan 180 mg injection, vial | has unit of use | vial | true | Inferred relationship | Some | 1027446846 | |
| sacituzumab govitecan 180 mg injection, vial | has intended active ingredient | sacituzumab govitecan | true | Inferred relationship | Some | 606802513 | |
| sacituzumab govitecan 180 mg injection, vial | has Australian BoSS | sacituzumab govitecan | true | Inferred relationship | Some | 606802513 |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Trodelvy 180 mg powder for injection, 180 mg vial | Is a | True | sacituzumab govitecan 180 mg injection, vial | Inferred relationship | Some | |
| sacituzumab govitecan 180 mg injection, 1 vial | has MPUU | True | sacituzumab govitecan 180 mg injection, vial | Inferred relationship | Some | 531075824 |
Reference Sets
Medicinal product unit of use reference set
FHIR